Literature DB >> 18215660

RelA/NF-kappaB transcription factor associates with alpha-actinin-4.

Vladimir N Babakov1, Olga A Petukhova, Lidia V Turoverova, Irina V Kropacheva, Dmitri G Tentler, Anastasia V Bolshakova, Ekaterina P Podolskaya, Karl-Eric Magnusson, George P Pinaev.   

Abstract

The NF-kappaB/RelA family of transcription factors regulates inducible transcription of a large number of genes in response to diverse stimuli. Little is known, however, about the location of NF-kappaB in the cytoplasm and the transport mechanism to the nucleus. We found that NF-kappaB is associated with the actin-binding protein alpha-actinin-4. NF-kappaB and alpha-actinin-4 co-localized along actin stress fibers and in membrane lamellae in A431 cells. After a 30-min stimulation with EGF or TNF-alpha, alpha-actinin-4 and p65 were found in the nucleus. Disruption of cytoskeleton by cytochalasin D prior to treatment with TNF-alpha led to increase of p65 nuclear translocation. Antibodies to p65 subunit of NF-kappaB co-immunoprecipitated alpha-actinin-4 from A431 cell lysates and nuclear extracts, but alpha-actinin-1 and beta-actin were not found in the precipitates. Affinity chromatography experiments displayed that p65 and p50 subunits of NF-kappaB can bind to matrix-bound chicken gizzard alpha-actinin. We suggest that the alpha-actinin-4 is important for the NF-kappaB nuclear translocation and its functions inside the nucleus.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18215660     DOI: 10.1016/j.yexcr.2007.12.001

Source DB:  PubMed          Journal:  Exp Cell Res        ISSN: 0014-4827            Impact factor:   3.905


  25 in total

1.  The actin-binding protein, actinin alpha 4 (ACTN4), is a nuclear receptor coactivator that promotes proliferation of MCF-7 breast cancer cells.

Authors:  Simran Khurana; Sharmistha Chakraborty; Xiwen Cheng; Yu-Ting Su; Hung-Ying Kao
Journal:  J Biol Chem       Date:  2010-11-15       Impact factor: 5.157

Review 2.  The Histochemistry and Cell Biology omnium-gatherum: the year 2015 in review.

Authors:  Douglas J Taatjes; Jürgen Roth
Journal:  Histochem Cell Biol       Date:  2016-02-15       Impact factor: 4.304

3.  ACTN4 regulates the stability of RIPK1 in melanoma.

Authors:  Yuan Yuan Zhang; Hessam Tabataba; Xiao Ying Liu; Jia Yu Wang; Xu Guang Yan; Margaret Farrelly; Chen Chen Jiang; Su Tang Guo; Tao Liu; Hung-Ying Kao; Rick F Thorne; Xu Dong Zhang; Lei Jin
Journal:  Oncogene       Date:  2018-04-30       Impact factor: 9.867

4.  EGF-induced dynamics of NF-κB and F-actin in A431 cells spread on fibronectin.

Authors:  Anastasia Bolshakova; Karl-Eric Magnusson; George Pinaev; Olga Petukhova
Journal:  Histochem Cell Biol       Date:  2015-05-20       Impact factor: 4.304

Review 5.  Rho, nuclear actin, and actin-binding proteins in the regulation of transcription and gene expression.

Authors:  Eeva Kaisa Rajakylä; Maria K Vartiainen
Journal:  Small GTPases       Date:  2014-03-06

Review 6.  Introducing STRaNDs: shuttling transcriptional regulators that are non-DNA binding.

Authors:  Min Lu; Mary R Muers; Xin Lu
Journal:  Nat Rev Mol Cell Biol       Date:  2016-05-25       Impact factor: 94.444

7.  Thymosin beta4 inhibits TNF-alpha-induced NF-kappaB activation, IL-8 expression, and the sensitizing effects by its partners PINCH-1 and ILK.

Authors:  Ping Qiu; Michelle Kurpakus Wheater; Yue Qiu; Gabriel Sosne
Journal:  FASEB J       Date:  2011-02-22       Impact factor: 5.191

8.  α-Actinin-4 is required for amoeboid-type invasiveness of melanoma cells.

Authors:  Hanshuang Shao; Shaoyan Li; Simon C Watkins; Alan Wells
Journal:  J Biol Chem       Date:  2014-10-08       Impact factor: 5.157

9.  α-Actinin-4 promotes metastasis in gastric cancer.

Authors:  Xin Liu; Kent-Man Chu
Journal:  Lab Invest       Date:  2017-06-05       Impact factor: 5.662

10.  α-Actinin-4 induces the epithelial-to-mesenchymal transition and tumorigenesis via regulation of Snail expression and β-catenin stabilization in cervical cancer.

Authors:  H-T An; S Yoo; J Ko
Journal:  Oncogene       Date:  2016-04-11       Impact factor: 9.867

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.